Search results
New AJOVY® (fremanezumab) Migraine Prevention Data Challenges Treatment Pauses
PharmiWeb· 6 days ago4th interim analysis of PEARL real world migraine prevention study presented at 10th European Association of Neurology (EAN) congress in Helsinki New sub-analysis of PEARL data highlights potential ...
FDA Approves Second Alzheimer’s Drug after Trial Shows it Can Slow Disease by 35%
The Daily Beast via Yahoo News UK· 4 days agoThe Federal Drug Administration gave the go-ahead to a second Alzheimer’s treatment Tuesday after a...
Roche (RHHBY) Gets Positive CHMP Recommendation for Its Drugs
Zacks via Yahoo Finance UK· 6 days agoRoche (RHHBY) gets CHMP recommendation for a label expansion of ophthalmology drug Vabysmo...
Delaying Dementia? New drug just approved
WDHN Dothan· 4 days agoU.S. officials have approved another Alzheimer’s drug that can modestly slow the disease, providing a new option for patients in the early stages of the...
Sobi initiates rolling biologics license application to FDA for SEL-212 for the potential treatment...
PharmiWeb· 5 days agoSEL-212 is an innovative biologic therapy in development for the treatment of chronic refractory gout, a debilitating condition characterised by the persistent and painful buildup of urate crystals ...
Thomasville Humane teams up with Elanco to fight parvovirus
Thomasville Times-Enterprise, Ga.· 5 days agoJul. 1—THOMASVILLE- Parvo-Canine virus season has arrived in Georgia and Florida. With nearly 500 cases already reported, Thomasville Humane has partnered with Elanco, the producers of a monoclonal ...
Merck (MRK) Gets Exclusive Rights to Opevesostat From Partner
Zacks via Yahoo Finance UK· 5 days agoMerck (MRK) exercises the option that will convert the collaboration deal with partner Orion for...
Loss of miR-145 promotes remyelination and functional recovery in a model of chronic central...
Nature· 3 days agoLoss of miR-145 promotes remyelination in a chronically demyelinated animal model, implicating it as a factor in remyelination failure in human Multiple Sclerosis lesions and highlighting in as a potential therapeutic target for progressive MS.
Cartesian (RNAC) MG Study Meets Goals, Stock Down on Other Updates
Zacks via Yahoo Finance UK· 3 days agoCartesian (RNAC) announced that the phase IIb study in MG patients has achieved its primary...
ESR1 Mutated Metastatic Breast Cancer Diagnostics Market is expected to grow at a CAGR of 11% and re
PharmiWeb· 3 days agoThe fight against breast cancer receives a crucial boost with advancements in diagnostic tools. Future Market Insights predicts the ESR1 Mutated Metastatic Breast Cancer Diagnostics Market to ...